Methods identifying prostate cancer, methods for prognosing and diagnosing
prostate cancer, methods for identifying a compound that modulates prostate cancer
development, methods for determining the efficacy of a prostate cancer therapy,
and oligonucleotide microarrays containing probes for genes involved in prostate
cancer development are described.